SCHEMBL31191386

SCHEMBL31191386

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.56
▸ MAPK9 P45984 1/20 0.56
▸ MAPK10 P53779 1/20 0.56
▸ KEAP1 Q14145 3/20 0.55
▸ OPRD1 P41143 2/20 0.52
▸ NMUR2 Q9GZQ4 4/20 0.52
▸ NMUR1 Q9HB89 4/20 0.52
▸ RAMP3 O60896 1/20 0.51
▸ CALCR P30988 1/20 0.51
▸ NTSR1 P30989 3/20 0.50
▸ NTSR2 O95665 2/20 0.50
▸ SORT1 Q99523 1/20 0.50
▸ EP300 Q09472 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ STAT3 P40763 1/20 0.50
▸ GLP1R P43220 1/20 0.49
▸ GCGR P47871 1/20 0.49
▸ GIPR P48546 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31191392 0.96 OPRD1 (0.52) MAPK8MAPK9MAPK10KEAP1OPRD1
SCHEMBL31191418 0.96 NMUR2 (0.56) MAPK8MAPK9MAPK10KEAP1OPRD1
SCHEMBL29679870 0.89 MAPK8 (0.54) MAPK8MAPK9MAPK10KEAP1NMUR2
SCHEMBL31191279 0.88 MAPK8 (0.58) MAPK8MAPK9MAPK10KEAP1OPRD1
SCHEMBL30429026 0.86 RAMP3 (0.58) MAPK8MAPK9MAPK10KEAP1NMUR2
SCHEMBL31419694 0.85 OPRD1 (0.56) MAPK8MAPK9MAPK10KEAP1OPRD1
SCHEMBL29730643 0.85 KEAP1 (0.56) KEAP1OPRD1NMUR2NMUR1RAMP3
SCHEMBL30429680 0.85 EP300 (0.61) MAPK8MAPK9MAPK10KEAP1CALCR
SCHEMBL31119607 0.85 IL23R (0.54) MAPK8MAPK9MAPK10KEAP1NMUR2
SCHEMBL30176479 0.84 MAPK8 (0.57) MAPK8MAPK9MAPK10KEAP1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166266-B Anti-mesothelin constructs and uses thereof 上海偌妥生物科技有限公司 2025-06-24 — — CN disclosed
US-12215130-B2 Cytokine-albumin binding moiety fusion proteins and uses thereof ANWITA BIOSCIENCES, INC. (US) 2025-02-04 — — US disclosed
US-12091438-B2 Anti-mesothelin constructs and uses thereof ANWITA BIOSCIENCES, INC. (US) 2024-09-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12091438-B2 Anti-mesothelin constructs and uses thereof IL15, IL15RA, EPS15 MAPK8 2972/4885MAPK9 2847/4885MAPK10 1764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback